Tag: Eli Lilly and Co
Leqembi could cost Medicare $5 billion per year
The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on Jan. 20, 2023.Eisai | ReutersThe new Alzheimer's antibody tr [...]
Eli Lilly vows insulin prices won’t rise; Novo Nordisk, Sanofi hedge
An Eli Lilly & Co. logo is seen on a box of insulin medication in this arranged photograph at a pharmacy in Princeton, Illinois.Daniel Acker | Blo [...]
Eli Lilly treatment donanemab slowed disease progression
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021.Mike Segar | Reut [...]
Patients may wait years for new drugs
Juanmonino | E+ | Getty ImagesSeniors with early Alzheimer's disease will face major hurdles to get treated even if promising new drugs roll out more [...]
Eli Lilly weight loss drug tirzepatide data released
Patients who took Eli Lilly's weight loss drug tirzepatide lost up to 34 pounds on average, or 16% of their body weight, the company said in clinical [...]
Eli Lilly (LLY) Q1 earnings 2023
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krako [...]
Biogen not worried about Alzheimer’s competition with Eli Lilly
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesBiogen [...]
Drug company CEOs will testify at Senate Health on insulin price
In this photo illustration, an insulin pen manufactured by the Novo Nordisk company is displayed on March 14, 2023 in Miami, Florida.Joe Raedle | Gett [...]
Don’t let the Fed’s meeting obscure investing opportunities
CNBC's Jim Cramer on Friday advised investors to keep their eyes peeled for chances to improve their portfolios next week."These big macro numbers and [...]
Jim Cramer says these 10 ‘old guard’ stocks are making a comeback
CNBC's Jim Cramer on Tuesday offered investors a list of 10 companies that he believes are rising to the top as tech stocks collapse."It's the revenge [...]
Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker's innovation pipeline Tuesday, a stance we share despite the Club h [...]
These 8 stocks can withstand the Fed’s tightening cycle
CNBC's Jim Cramer on Tuesday offered investors a list of stocks that he thinks will weather the market turbulence ahead.Here are his picks:Constellati [...]
There could be ‘real signs’ for the Fed to slow down
CNBC's Jim Cramer on Friday said that next week's jam-packed week of earnings and economic data releases could result in good news for the Federal Res [...]
We like health care and staples, Club names in the news
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Monday's key moments. H [...]
These two strategies can help you stay diversified in any kind of stock market
Using correlations and the barbell strategy can help inform trading decisions in any market.
www.cnbc.com [...]